Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 115 Records) |
Query Trace: Breast Neoplasms and NODAL[original query] |
---|
Predictive Role of TP53, PIK3CA and MLL2 in ER+ HER2+ Breast Bancer: Biomarker Analysis of Neo-ALL-IN [NCT 01275859]. Anticancer research 2020 9 40 (10): 5883-5893. Park Ji Hyun, Ahn Jin-Hee, Kim Jeong Eun, Jung Kyung Hae, Gong Gyungyub, Lee Hee Jin, Son Byung-Ho, Ahn Sei-Hyun, Kim Hak-Hee, Shin Hee Jung, Moon Dae-Hyuk, Kim Deokhoon, Kim Sung-B |
Evaluation of PIG-A-mutated granulocytes and ex-vivo binucleated micronucleated lymphocytes frequencies after breast cancer radiotherapy in humans. Environmental and molecular mutagenesis 2020 11 62 (1): 18-28. Bonetto Rémi M, Castel Pierre, Robert Stéphane P, Tassistro Virginie M, Claeys-Bruno Magalie, Sergent Michelle, Delecourt Camille A, Cowen Didier, Carcopino Xavier, Orsière Thierry |
Ultradeep targeted sequencing of circulating tumor DNA in plasma of early and advanced breast cancer. Cancer science 2020 Oct . Chin Yoon Ming, Takahashi Yoko, Chan Hiu Ting, Otaki Masumi, Fujishima Makoto, Shibayama Tomoko, Miki Yoshio, Ueno Takayuki, Nakamura Yusuke, Low Siew-K |
Breast Radiation Therapy-Related Treatment Outcomes in Patients With or Without Germline Mutations on Multigene Panel Testing. International journal of radiation oncology, biology, physics 2021 9 112 (2): 437-444. Chapman Bhavana V, Liu Diane, Shen Yu, Olamigoke Oluwafikayo O, Lakomy David S, Barrera Angelica M Gutierrez, Stecklein Shane R, Sawakuchi Gabriel O, Bright Scott J, Bedrosian Isabelle, Litton Jennifer K, Smith Benjamin D, Woodward Wendy A, Perkins George H, Hoffman Karen E, Stauder Michael C, Strom Eric A, Arun Banu K, Shaitelman Simona |
The significance of HOXB7 and IL17RB serum levels in prognosis of hormonally dependent breast cancer: A pilot study. Advances in medical sciences 2021 7 66 (2): 359-365. Todorovi?-Rakovi? Nataša, Milovanovi? Jelena, Greenman John, Radulovic Mar |
Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy. Frontiers in oncology 2021 11 736769. Lin Po-Han, Wang Ming-Yang, Lo Chiao, Tsai Li-Wei, Yen Tzu-Chun, Huang Thomas Yoyan, Huang Wei-Chih, Yang Karen, Chen Chih-Kai, Fan Sheng-Chih, Kuo Sung-Hsin, Huang Chiun-She |
The Role of US in Depicting Axillary Metastasis in High-Risk Breast Cancer Patients. Journal of personalized medicine 2021 12 11 (12): . Pintican Roxana, Duma Magdalena Maria, Szep Madalina, Feier Diana, Eniu Dan, Goidescu Iulian, Chiorean Angeli |
Clinical and genomic analyses of neuroendocrine neoplasms of the breast. Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2021 Nov . Wei Yani, Ke Xuexuan, Yu Jiaxiu, Jing Qiuyang, Bu Hong, Zeng Xiangfei, Wei Bi |
Outcomes After Breast Radiation Therapy in a Diverse Patient Cohort With a Germline BRCA1/2 Mutation. International journal of radiation oncology, biology, physics 2021 Oct . Chapman Bhavana V, Liu Diane, Shen Yu, Olamigoke Oluwafikayo O, Lakomy David S, Barrera Angelica M Gutierrez, Stecklein Shane R, Sawakuchi Gabriel O, Bright Scott J, Bedrosian Isabelle, Litton Jennifer K, Smith Benjamin D, Woodward Wendy A, Perkins George H, Hoffman Karen E, Stauder Michael C, Strom Eric A, Arun Banu K, Shaitelman Simona |
Clustering Molecular Subtypes in Breast Cancer, Immunohistochemical Parameters and Risk of Axillary Nodal Involvement. Journal of personalized medicine 2022 9 12 (9): . Pereira Augusto, Siegrist Jaime, Lizarraga Santiago, Pérez-Medina Tir |
Clinical Validation of EndoPredict in Pre-Menopausal Women with ER-Positive, HER2-Negative Primary Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2022 8 28 (20): 4435-4443. Constantinidou Anastasia, Marcou Yiola, Toss Michael S, Simmons Timothy, Bernhisel Ryan, Hughes Elisha, Probst Braden, Meek Stephanie, Kakouri Eleni, Georgiou Georgios, Zouvani Ioanna, Savvidou Gabriella, Kuhl Vanessa, Doedt Jennifer, Wagner Susanne, Gutin Alexander, Slavin Thomas P, Lanchbury Jerry S, Kronenwett Ralf, Ellis Ian O, Rakha Emad |
Association of 21-gene recurrence score and locoregional recurrence in early breast cancer patients. Cancer biomarkers : section A of Disease markers 2022 35 (1): 111-118. Zeng Yufei, Gao Weiqi, Chen Xiaosong, Shen Kunw |
The role of Prolactin/Prolactin Receptor polymorphisms and expression in breast cancer susceptibility and outcome. Translational cancer research 2022 2 9 (10): 6344-6353. Sa-Nguanraksa Doonyapat, Thasripoo Cholladda, Samarnthai Norasate, Kummalue Tanawan, Thumrongtaradol Thanawat, O-Charoenrat Pornch |
[SCREENING WOMEN AT HIGH RISK FOR BREAST CANCER - BRCA AND BEYOND]. Harefuah 2022 2 161 (2): 95-100. Hermann Naama, Westergard Shelley, McCready David |
The clinicopathological and prognostic significances of LATS1 expression in breast cancer. Histology and histopathology 2022 Feb 18433. Zheng Hua-Chuan, Xiang Li-Wei, Cui Zheng-Guo, Xue Hang, E Ying, Zhao Ming-Zh |
De-Implementation of Low-Value Care for Women 70 Years of Age or Older with Low-Risk Breast Cancer During the COVID-19 Pandemic. Annals of surgical oncology 2023 8 . Ton Wang, Christina Weed, Joshua Tseng, Alice Chung, Marissa K Boyle, Farin Amersi, Jaswinder Jutla, Amin Mirhadi, Armando E Giulia |
Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients. Breast cancer research and treatment 2023 8 . Aysun Dauti Isiklar, Lamiya Aliyeva, Ahmet Yesilyurt, Aykut Soyder, Gul Basar |
Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients. Frontiers in immunology 2023 6 14 1188030. Oliver Hoffmann, Sebastian Wormland, Ann-Kathrin Bittner, Julian Hölzenbein, Esther Schwich, Sabine Schramm, Hana Rohn, Peter A Horn, Rainer Kimmig, Sabine Kasimir-Bauer, Vera Rebma |
Association of mutation and expression of the brother of the regulator of imprinted sites (BORIS) gene with breast cancer progression. Oncotarget 2023 5 14 528-541. Mohammad Salman Akhtar, Naseem Akhter, Arshi Talat, Raed A Alharbi, Abdulmajeed A A Sindi, Faisal Klufah, Hanan E Alyahyawi, Abdulmohsen Alruwetei, Abrar Ahmad, Mazin A Zamzami, Svs Deo, Syed Akhtar Husain, Osama A Badi, Mohammad Jahir Kh |
TP53 Signature Can Predict Pathological Response From Neoadjuvant Chemotherapy and Is a Prognostic Factor in Patients With Residual Disease. Breast cancer : basic and clinical research 2023 5 17 11782234231167655. Shin Takahashi, Keiju Sasaki, Chikashi Ishio |
Early increase in tamoxifen dose in CYP2D6 poor metaboliser breast cancer patients and survival: A propensity score matching analysis. Breast (Edinburgh, Scotland) 2023 4 69 342-348. Blancas Isabel, Linares-Rodríguez Marina, Martínez de Dueñas Eduardo, Herrero-Vicent Carmen, Molero-Mir María D, Garrido José M, Rodríguez-Serrano Fernan |
Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer. BMC cancer 2023 4 23 (1): 330. Ma Sung Jun, Gill Jasmin, Yendamuri Keerti, Chatterjee Udit, Waldman Olivia, Dunne-Jaffe Cynthia, Fekrmandi Fatemeh, Shekher Rohil, Iovoli Austin, Yao Song, Oladeru Oluwadamilola T, Singh Anurag |
Mutational Status is Associated with a Higher Rate of Pathologic Complete Response After Neoadjuvant Chemotherapy in Hormone Receptor-Positive Breast Cancer. Annals of surgical oncology 2023 10 . Sara P Myers, Varadan Sevilimedu, Andrea V Barrio, Audree B Tadros, Anita Mamtani, Mark E Robson, Monica Morrow, Minna K L |
Estrogen receptor alpha (ESR1) gene polymorphism (rs2234693 and rs2046210) with breast cancer risk in pashtun population of Khyber Pakhtunkhwa. Molecular biology reports 2023 1 50 (3): 2445-2451. Shahzad Savera, Khan Najeeb Ullah, Sombal Wafa, Shah Rizwan Ullah, Khan Aakif Ullah, Iqbal Aqib, Munir Iqb |
Novel Association of IGF2BP2 Gene Variants With Altered Risk of Breast Cancer and as Potential Molecular Biomarker of Triple Negative Breast Cancer. Clinical breast cancer 2023 1 . Almawi Wassim Y, Zidi Sabrina, Sghaier Ikram, El-Ghali Rabeb M, Daldoul Amira, Midlenko An |
General analysis of breast cancer patients tested for BRCA mutations and evaluation of acute radiotherapy toxicity. Northern clinics of Istanbul 2024 8 11 (4): 302-308. Sule Karabulut Gul, Huseyin Tepetam, Berrin Benli Yavuz, Ozge Kandemir Gursel, Ayse Altinok, Irem Yuksel, Omar Alomari, Banu Atalar, Ilknur Bilkay Gork |
Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers. NPJ breast cancer 2024 7 10 (1): 63. Sara P Myers, Varadan Sevilimedu, Andrea V Barrio, Audree B Tadros, Anita Mamtani, Mark E Robson, Monica Morrow, Minna K L |
Association analysis of miRNA-146a and miRNA-196a polymorphism with breast cancer risk in Khyber Pakhtunkhwa, Pakistan: a preliminary study. Molecular biology reports 2024 7 51 (1): 827. Gul I Hina, Najeeb Ullah Khan, Sidra Tul Muntaha, Asad Ullah, Sherhayat Khan, Abdullah R Alanzi, Ijaz Ali, Tianhui Ch |
PIK3CA mutations in endocrine-resistant breast cancer. Scientific reports 2024 5 14 (1): 12542. Caroline Schagerholm, Stephanie Robertson, Hosein Toosi, Emmanouil G Sifakis, Johan Hartm |
Survival and inferential analysis in patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and subsequent sentinel lymph node biopsy: prospective single-center study. EJNMMI reports 2024 5 8 (1): 14. Johanna Marcela Espejo Ni |
- Page last reviewed:Feb 1, 2024
- Content source: